Cogent Biosciences (COGT) Operating Leases (2019 - 2021)
Historic Operating Leases for Cogent Biosciences (COGT) over the last 3 years, with Q3 2021 value amounting to $1.4 million.
- Cogent Biosciences' Operating Leases fell 6104.04% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year decrease of 6104.04%. This contributed to the annual value of $3.2 million for FY2020, which is 2850.67% down from last year.
- Latest data reveals that Cogent Biosciences reported Operating Leases of $1.4 million as of Q3 2021, which was down 6104.04% from $2.0 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Operating Leases registered a high of $5.6 million during Q1 2019, and its lowest value of $1.4 million during Q3 2021.
- In the last 3 years, Cogent Biosciences' Operating Leases had a median value of $3.7 million in 2020 and averaged $3.7 million.
- As far as peak fluctuations go, Cogent Biosciences' Operating Leases tumbled by 2359.76% in 2020, and later crashed by 6104.04% in 2021.
- Cogent Biosciences' Operating Leases (Quarter) stood at $4.4 million in 2019, then decreased by 28.51% to $3.2 million in 2020, then plummeted by 54.42% to $1.4 million in 2021.
- Its Operating Leases was $1.4 million in Q3 2021, compared to $2.0 million in Q2 2021 and $2.6 million in Q1 2021.